Differential Proteasomal Processing of Hydrophobic and Hydrophilic Protein Regions: Contribution to Cytotoxic T Lymphocyte Epitope Clustering in HIV-1-Nef

Total Page:16

File Type:pdf, Size:1020Kb

Differential Proteasomal Processing of Hydrophobic and Hydrophilic Protein Regions: Contribution to Cytotoxic T Lymphocyte Epitope Clustering in HIV-1-Nef Differential proteasomal processing of hydrophobic and hydrophilic protein regions: Contribution to cytotoxic T lymphocyte epitope clustering in HIV-1-Nef Maria Lucchiari-Hartz*, Viv Lindo†, Niclas Hitziger*, Simone Gaedicke*, Loredana Saveanu‡, Peter M. van Endert‡, Fiona Greer†, Klaus Eichmann*, and Gabriele Niedermann*§ *Department of Cellular Immunology, Max Planck Institute of Immunobiology, Stu¨beweg 51, D-79108 Freiburg, Germany; †M-SCAN Ltd., Silwood Park, Sunninghill, Ascot SL5 7PZ, United Kingdom; and ‡Institut National de la Sante´et de la Recherche Me´dicale U25, Hoˆpital Necker, F-75743 Paris Cedex 15, France Communicated by Richard M. Krause, National Institutes of Health, Bethesda, MD, April 15, 2003 (received for review February 20, 2003) HIV proteins contain a multitude of naturally processed cytotoxic T is located in the cytoplasm and temporarily attached to the cell lymphocyte (CTL) epitopes that concentrate in clusters. The molecular membrane via myristoylation (14, 15). It is a potent CTL antigen basis of epitope clustering is of interest for understanding HIV and reveals a typical pattern of high-density CTL epitope clusters immunogenicity and for vaccine design. We show that the CTL (refs. 1 and 16 and HIV Molecular Immunology Database). Nef- epitope clusters of HIV proteins predominantly coincide with hydro- specific CTLs may be particularly important in the control of HIV phobic regions, whereas the noncluster regions are predominantly infection, because Nef is the predominant transcript early after hydrophilic. Analysis of the proteasomal degradation products of infection and, perhaps as the only HIV protein, is expressed even full-length HIV-Nef revealed a differential sensitivity of cluster and before proviral integration (17, 18). In addition, primary HIV- noncluster regions to proteasomal processing. Compared with the infected T cells are lysed efficiently by Nef-specific CTLs (19), epitope-scarce noncluster regions, cluster regions are digested by whereas abrogation of recognition by Gag- and polymerase-specific proteasomes more intensively and with greater preference for hy- CTLs has been reported due to the Nef-mediated down-regulation drophobic P1 residues, resulting in substantially greater numbers of of HLA-A and HLA-B molecules (20). fragments with the sizes and COOH termini typical of epitopes and We recently reported that proteasome inhibitors abrogated CTL their precursors. Indeed, many of these fragments correspond to recognition of several Nef epitopes on Nef-expressing cells, sug- endogenously processed Nef epitopes and͞or their potential precur- gesting proteasome involvement in the processing of HIV-Nef (21). sors. The results suggest that differential proteasomal processing Now we have digested recombinant full-length Nef protein with contributes importantly to the clustering of CTL epitopes in hydro- isolated proteasomes, comprehensively analyzed the cleavage prod- phobic regions. ucts, and compared them with database epitope maps and a panel of naturally processed class I-binding Nef peptides determined by omprehensive analyses of several HIV antigens including Nef us. Our data suggest that the pronounced sensitivity of hydrophobic Chave revealed an enormous diversity of epitopes recognized by protein regions to proteasomal processing contributes importantly cytotoxic T lymphocytes (CTLs) of HIVϩ patients (see the HIV to the generation of an enormous multiplicity of extensively over- Molecular Immunology Database, http:͞͞hiv-web.lanl.gov͞ lapping CTL epitope peptides and to their clustering in hydrophobic content͞immunology). Moreover, HIV CTL epitopes extensively protein regions. overlap in so-called epitope clusters, whereas other regions of the HIV proteins are almost completely devoid of CTL epitopes (refs. Methods 1–6 and HIV Molecular Immunology Database). Evidence for Digestion of Recombinant Nef with Purified Proteasomes. The nef CTL epitope clusters exists also for non-HIV antigens (7). Al- gene of the HIV-1 LAI isolate was inserted into a variant (pRP261, though CTL epitope clusters often coincide with rather conserved kindly provided by B. Wollscheid, Max-Planck-Institut fu¨r Immun- regions of the HIV proteins (1, 4, 6), it has been postulated that the biologie, Freiburg, Germany) of the pGEX-3X-vectors (Amersham highly nonuniform distribution of HIV CTL epitopes may be Pharmacia) to generate a Nef-glutathione S-transferase fusion related to antigen processing and presentation (2, 4, 6). protein. Purification used glutathione-Sepharose 4B, and the Nef Proteasomes seem to participate in the generation of many if not protein was cleaved off by incubation with thrombin and purified most CTL epitopes. In the classical class I antigen-processing further by RP-HPLC. 20S proteasomes were purified from the pathway proteasomes generate epitopes as well as precursors that human lymphoblastoid cell line T1 as described (21). Recombinant are trimmed by cytosolic and endoplasmic reticulum-resident amin- Nef (60 ␮g) was digested with isolated proteasomes (2 ␮g) at 37°C opeptidases. Trimming by carboxypeptidases seems to be highly in a total volume of 300 ␮l of buffer (20 mM Hepes, pH 7.3͞1mM ͞ ͞ unusual. Cytosolic endoproteases other than proteasomes may be EGTA 5 mM MgCl2 0.5 mM 2-mercaptoethanol). The reaction involved in the production of certain epitopes, but thus far none mixture was fractionated by RP-HPLC on a Smart system (Amer- have been unequivocally identified (for several excellent reviews, sham Pharmacia) equipped with a Sephasil C18 SC2.1͞10 column see ref. 8 and all articles in the same issue). Important information with 0.1% trifluoroacetic acid (eluent A) and 80% acetonitrile on the role of proteasomes in antigen processing has been obtained containing 0.081% trifluoroacetic acid (eluent B). Degradation by in vitro digestion of proteins and protein fragments with isolated products were separated on a gradient of 10–55% B in 50 min and IMMUNOLOGY proteasomes. However, thus far analyses of CTL epitope- eluted between 16͞17% and 52% of eluent B. Aliquots of the containing full-length antigens (ovalbumin and ␤-galactosidase) (9, HPLC fractions were analyzed by matrix-associated laser desorp- 10) and most antigen fragments focused on a single epitope and͞or tion ionization͞time-of-flight MS with a Voyager STR spectrom- related epitope precursors. In nearly all experiments with CTL eter coupled with delayed extraction (Applied Biosystems; lower epitope-containing substrates, 20S proteasomes were used, and molecular mass limit, 400–450 Da). In some cases, sequences were excellent correlations with epitope recognition on antigen- presenting cells were often reported (11–13). The HIV protein Nef is a small regulatory protein and critical for Abbreviation: CTL, cytotoxic T lymphocyte. the development of the acquired immunodeficiency syndrome. Nef §To whom correspondence should be addressed. E-mail: [email protected]. www.pnas.org͞cgi͞doi͞10.1073͞pnas.1232228100 PNAS ͉ June 24, 2003 ͉ vol. 100 ͉ no. 13 ͉ 7755–7760 Downloaded by guest on September 23, 2021 Fig. 1. Map of the HIV-1-Nef pro- tein showing CTL epitope peptides and proteasomal cleavage products. CTL epitope peptides are shown above the sequence. Black lines are those recognized by CTLs of HIV- infected subjects as recorded in the HIV Molecular Immunology Data- base. Red lines are the naturally pro- cessed peptides acid-eluted from Nef- transfected cells (see also Table 1). The 20S proteasomal cleavage prod- ucts of recombinant HIV-1-Nef (LAI) protein are indicated as lines below the sequence. Fragments correspond- ing to acid-eluted HLA class I ligands are highlighted in red; fragments cor- responding to their potential precur- sor peptides are highlighted in green. *, Epitopes identified by immuniza- tion of HLA-A2 transgenic mice with HIV-1-Nef (HXB3), with the sequences ALTSSNTA and MTYKAALDL instead of AITSSNTA and MTYKAAVDL (LAI); **, a 20-aa sequence (Nef161–180) where a CTL epitope of unknown HLA restriction was located; ***, sub- dominant epitope with the sequence DPEKEVLQWK (LAI sequence, DPER- EVLEWR). confirmed by tandem-MS analysis on a Micromass Q-TOF instru- analysis, regions 68–146 and 180–206 were taken as epitope clus- ment. Aliquots of reconstituted fractions were also tested for ters, and regions 1–67 and 147–179 were taken as noncluster recognition by Nef-peptide-specific CTL in a 51Cr-release assay on regions. Although cluster and noncluster regions each cover ap- P815 murine mastocytoma cells transfected with HLA-A2, HLA- proximately half (106͞100 aa) of the Nef sequence, we detected B7, or HLA-A3. three times as many proteasomal cleavage products in the former (107 vs. 36), corresponding to twice the density of proteasomal Identification of Naturally Processed Nef Peptides and in Vitro Induc- cleavage sites in the epitope-cluster regions compared with the tion of Primary Nef-Specific CTL Lines. Naturally processed Nef noncluster regions (1͞1.5 vs. 1͞3.1 aa). peptides were identified essentially as described (21). Briefly, The sizes of the proteasomal cleavage products are given in Fig. peptides acid-eluted from Nef-transfected cells (HLA-A2.1ϩ T1, 2. Very few were shorter than 8 aa. For all peptides of 8 aa and HLA-B7.2ϩ Jurkat, or C1R cells transfected with HLA-A3) were longer, i.e., sizes potentially giving rise to MHC class I ligands, 2.6 fractionated by RP-HPLC with shallow gradients specifically de- times as many (92 vs. 35) were found in the cluster as in the signed to
Recommended publications
  • The Global Architecture Shaping the Heterogeneity and Tissue-Dependency of the MHC Class I Immunopeptidome Is Evolutionarily Conserved
    bioRxiv preprint doi: https://doi.org/10.1101/2020.09.28.317750; this version posted September 29, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The Global Architecture Shaping the Heterogeneity and Tissue-Dependency of the MHC Class I Immunopeptidome is Evolutionarily Conserved Authors Peter Kubiniok†1, Ana Marcu†2,3, Leon Bichmann†2,4, Leon Kuchenbecker4, Heiko Schuster1,5, David Hamelin1, Jérome Despault1, Kevin Kovalchik1, Laura Wessling1, Oliver Kohlbacher4,7,8,9,10 Stefan Stevanovic2,3,6, Hans-Georg Rammensee2,3,6, Marian C. Neidert11, Isabelle Sirois1, Etienne Caron1,12* Affiliations *Corresponding and Leading author: Etienne Caron ([email protected]) †Equal contribution to this work 1CHU Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada 2Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Baden-Württemberg, 72076, Germany. 3Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Baden-Württemberg, 72076, Germany. 4Applied Bioinformatics, Dept. of Computer Science, University of Tübingen, Tübingen, Baden- Württemberg, 72074, Germany. 5Immatics Biotechnologies GmbH, Tübingen, 72076, Baden-Württemberg, Germany. 6DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Baden- Württemberg, 72076, Germany. 7Institute for Bioinformatics and Medical Informatics,
    [Show full text]
  • Serine Proteases with Altered Sensitivity to Activity-Modulating
    (19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • REVIEW ARTICLE High Molecular Mass Intracellular Proteases
    Biochem J. (1989) 263, 625-633 (Printed in Great Britain) 625 REVIEW ARTICLE High molecular mass intracellular proteases A. Jennifer RIVETT Department of Biochemistry, University of Leicester, Leicester LE'l 7RH, U.K. INTRODUCTION demonstrated that intracellular proteolysis is not re- Many of the well-characterized proteolytic enzymes, stricted to the lysosomes. Since a large proportion of and particularly those for which X-ray structures are intracellular protein breakdown, especially the degra- now available, are small monomeric enzymes often dation of proteins with short half-lives, is now known to having molecular masses in the range of 20-30 kDa. occur by nonlysosomal mechanisms (Mayer & Doherty, Many of them are extracellular enzymes which are easy 1986; Bond & Beynon, 1987; Rechsteiner, 1987; Bohley, to assay and to purify. With a growing awareness of the 1987; Rivett, 1989b; Katunuma & Kominami, 1989; importance of intracellular protein turnover and Knecht & Grisolia, 1989), there is now a greater interest mechanisms of intracellular protein breakdown, interest in nonlysosomal degradation systems and in nonlyso- in the proteases responsible has also increased. Although somal proteinases, many of which have large complex some intracellular proteases, especially those found structures. within the lysosomes in animal cells, are, like extracellular In contrast to the well-known lysosomal proteases, proteases, small and highly active monomeric enzymes, soluble extralysosomal proteases often have multimeric a number of cellular proteases
    [Show full text]
  • Reticulum-Resident Peptidases Activities of Cytosolic And
    The Efficiency of Human Cytomegalovirus pp65 495−503 CD8+ T Cell Epitope Generation Is Determined by the Balanced Activities of Cytosolic and Endoplasmic This information is current as Reticulum-Resident Peptidases of September 30, 2021. Sabrina Urban, Kathrin Textoris-Taube, Barbara Reimann, Katharina Janek, Tanja Dannenberg, Frédéric Ebstein, Christin Seifert, Fang Zhao, Jan H. Kessler, Anne Halenius, Petra Henklein, Julia Paschke, Sandrine Cadel, Helga Downloaded from Bernhard, Ferry Ossendorp, Thierry Foulon, Dirk Schadendorf, Annette Paschen and Ulrike Seifert J Immunol published online 15 June 2012 http://www.jimmunol.org/content/early/2012/06/15/jimmun ol.1101886 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2012/06/15/jimmunol.110188 Material 6.DC1 Why The JI? Submit online. by guest on September 30, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright
    [Show full text]
  • Studies of Structure and Function of Tripeptidyl-Peptidase II
    Till familj och vänner List of Papers This thesis is based on the following papers, which are referred to in the text by their Roman numerals. I. Eriksson, S.; Gutiérrez, O.A.; Bjerling, P.; Tomkinson, B. (2009) De- velopment, evaluation and application of tripeptidyl-peptidase II se- quence signatures. Archives of Biochemistry and Biophysics, 484(1):39-45 II. Lindås, A-C.; Eriksson, S.; Josza, E.; Tomkinson, B. (2008) Investiga- tion of a role for Glu-331 and Glu-305 in substrate binding of tripepti- dyl-peptidase II. Biochimica et Biophysica Acta, 1784(12):1899-1907 III. Eklund, S.; Lindås, A-C.; Hamnevik, E.; Widersten, M.; Tomkinson, B. Inter-species variation in the pH dependence of tripeptidyl- peptidase II. Manuscript IV. Eklund, S.; Kalbacher, H.; Tomkinson, B. Characterization of the endopeptidase activity of tripeptidyl-peptidase II. Manuscript Paper I and II were published under maiden name (Eriksson). Reprints were made with permission from the respective publishers. Contents Introduction ..................................................................................................... 9 Enzymes ..................................................................................................... 9 Enzymes and pH dependence .............................................................. 11 Peptidases ................................................................................................. 12 Serine peptidases ................................................................................. 14 Intracellular protein
    [Show full text]
  • Supplemental Table 1
    Symbol Gene name MIN6.EXO MIN6.M1 MIN6.M2 MIN6.M3 MIN6.M4 A2m alpha-2-macroglobulin A2m Acat1 acetyl-Coenzyme A acetyltransferase 1 Acat1 Acly ATP citrate lyase Acly Acly Acly Act Actin Act Act Act Act Aga aspartylglucosaminidase Aga Ahcy S-adenosylhomocysteine hydrolase Ahcy Alb Albumin Alb Alb Alb Aldoa aldolase A, fructose-bisphosphate Aldoa Anxa5 Annexin A5 Anxa5 AP1 Adaptor-related protein complex AP1 AP2 Adaptor protein complex AP2 Arf1 ADP-ribosylation factor 1 Arf1 Atp1a1 ATPase Na/K transpoting Atp1a1 ATP1b1 Na/K ATPase beta subunit ATP1b1 ATP6V1 ATPase, H+ transporting.. ATP6V1 ATP6v1 ATP6v1 Banf1 Barrier to autointegration factor Banf1 Basp1 brain abundant, memrane signal protein 1 Basp1 C3 complement C3 C3 C3 C3 C4 Complement C4 C4 C4 C4 Calm2 calmodulin 2 (phosphorylase kinase, delta) Calm2 Capn5 Calpain 5 Capn5 Capn5 Cct5 chaperonin subunit 5 Cct5 Cct8 chaperonin subunit 8 Cct8 CD147 basigin CD147 CD63 CD63 CD63 CD81 CD81 CD81 CD81 CD81 CD81 CD81 CD82 CD82 CD82 CD82 CD90.2 thy1.2 CD90.2 CD98 Slc3a2 CD98 CD98 Cdc42 Cell division cycle 42 Cdc42 Cfl1 Cofilin 1 Cfl1 Cfl1 Chmp4b chromatin modifying protein 4B Chmp4b Chmp5 chromatin modifying protein 5 Chmp5 Clta clathrin, light polypeptide A Clta Cltc Clathrin Hc Cltc Cltc Cltc Cltc Clu clusterin Clu Col16a1 collagen 16a1 Col16a1 Col2 Collagen type II Col2a1 Col2 Col6 Collagen type VI alpha 3 Col6a3 Col6 CpE carboxypeptidase E CpE CpE CpE, CpH CpE CpE Cspg4 Chondroitin sulfate proteoglycan 4 Cspg4 CyCAP Cyclophilin C-associated protein CyCAP CyCAP Dnpep aspartyl aminopeptidase Dnpep Dstn destrin Dstn EDIL3 EGF-like repeat discoidin.
    [Show full text]
  • Correlation of Serpin–Protease Expression by Comparative Analysis of Real-Time PCR Profiling Data
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Genomics 88 (2006) 173–184 www.elsevier.com/locate/ygeno Correlation of serpin–protease expression by comparative analysis of real-time PCR profiling data Sunita Badola a, Heidi Spurling a, Keith Robison a, Eric R. Fedyk a, Gary A. Silverman b, ⁎ Jochen Strayle c, Rosana Kapeller a,1, Christopher A. Tsu a, a Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, MA 02139, USA b Department of Pediatrics, University of Pittsburgh School of Medicine, Magee-Women’s Hospital, 300 Halket Street, Pittsburgh, PA 15213, USA c Bayer HealthCare AG, 42096 Wuppertal, Germany Received 2 December 2005; accepted 27 March 2006 Available online 18 May 2006 Abstract Imbalanced protease activity has long been recognized in the progression of disease states such as cancer and inflammation. Serpins, the largest family of endogenous protease inhibitors, target a wide variety of serine and cysteine proteases and play a role in a number of physiological and pathological states. The expression profiles of 20 serpins and 105 serine and cysteine proteases were determined across a panel of normal and diseased human tissues. In general, expression of serpins was highly restricted in both normal and diseased tissues, suggesting defined physiological roles for these protease inhibitors. A high correlation in expression for a particular serpin–protease pair in healthy tissues was often predictive of a biological interaction. The most striking finding was the dramatic change observed in the regulation of expression between proteases and their cognate inhibitors in diseased tissues.
    [Show full text]
  • Proteases in MHC Class I Presentation and Cross-Presentation Kenneth L
    Proteases in MHC Class I Presentation and Cross-Presentation Kenneth L. Rock, Diego J. Farfán-Arribas and Lianjun Shen This information is current as J Immunol 2010; 184:9-15; ; of October 1, 2021. doi: 10.4049/jimmunol.0903399 http://www.jimmunol.org/content/184/1/9 References This article cites 79 articles, 36 of which you can access for free at: Downloaded from http://www.jimmunol.org/content/184/1/9.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: by guest on October 1, 2021 http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2010 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Proteases in MHC Class I Presentation and Cross-Presentation Kenneth L. Rock, Diego J. Farfa´n-Arribas, and Lianjun Shen Cells that have mutated their genes or are virally is tolerant to them. However, if cells are synthesizing mutant infected are a potential threat to a host. Consequently, proteins or ones from viruses, then peptides from these gene the immune system has evolved mechanisms for CD8 T products will also be displayed, and this allows effector CD8 lymphocytes to identify such cells and eliminate them.
    [Show full text]
  • Uva-DARE (Digital Academic Repository)
    UvA-DARE (Digital Academic Repository) Peptidases in antigen processing and neurodegenerative diseases Raspe, M.A. Publication date 2011 Link to publication Citation for published version (APA): Raspe, M. A. (2011). Peptidases in antigen processing and neurodegenerative diseases. General rights It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible. UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl) Download date:26 Sep 2021 CHAPTER 3 Tripeptidyl peptidase II, the cure for nearly everything? Marcel A. Raspe Eric A. Reits1 Department of Cell Biology and Histology, Academic Medical Center, Amsterdam, The Netherlands 1 Author for correspondence [email protected] Manuscript in preperation Chapter 3 Abs Protein degradation is as important for the viability of an organism as protein synthesis. The major pathway to degrade intracellular proteins is the ubiquitin-proteasome system.
    [Show full text]
  • A Genomic Analysis of Rat Proteases and Protease Inhibitors
    A genomic analysis of rat proteases and protease inhibitors Xose S. Puente and Carlos López-Otín Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Instituto Universitario de Oncología, Universidad de Oviedo, 33006-Oviedo, Spain Send correspondence to: Carlos López-Otín Departamento de Bioquímica y Biología Molecular Facultad de Medicina, Universidad de Oviedo 33006 Oviedo-SPAIN Tel. 34-985-104201; Fax: 34-985-103564 E-mail: [email protected] Proteases perform fundamental roles in multiple biological processes and are associated with a growing number of pathological conditions that involve abnormal or deficient functions of these enzymes. The availability of the rat genome sequence has opened the possibility to perform a global analysis of the complete protease repertoire or degradome of this model organism. The rat degradome consists of at least 626 proteases and homologs, which are distributed into five catalytic classes: 24 aspartic, 160 cysteine, 192 metallo, 221 serine, and 29 threonine proteases. Overall, this distribution is similar to that of the mouse degradome, but significatively more complex than that corresponding to the human degradome composed of 561 proteases and homologs. This increased complexity of the rat protease complement mainly derives from the expansion of several gene families including placental cathepsins, testases, kallikreins and hematopoietic serine proteases, involved in reproductive or immunological functions. These protease families have also evolved differently in the rat and mouse genomes and may contribute to explain some functional differences between these two closely related species. Likewise, genomic analysis of rat protease inhibitors has shown some differences with the mouse protease inhibitor complement and the marked expansion of families of cysteine and serine protease inhibitors in rat and mouse with respect to human.
    [Show full text]
  • Tripeptidyl-Peptidase II: Update on an Oldie That Still Counts
    Biochimie 166 (2019) 27e37 Contents lists available at ScienceDirect Biochimie journal homepage: www.elsevier.com/locate/biochi Review Tripeptidyl-peptidase II: Update on an oldie that still counts Birgitta Tomkinson Department of Medical Biochemistry and Microbiology, Uppsala University, Box 582, SE-751 23, Uppsala, Sweden article info abstract Article history: The huge exopeptidase, tripeptidyl-peptidase II (TPP II), appears to be involved in a large number of Received 26 February 2019 important biological processes. It is present in the cytosol of most eukaryotic cells, where it removes Accepted 14 May 2019 tripeptides from free amino termini of longer peptides through a ‘molecular ruler mechanism’. Its main Available online 17 May 2019 role appears to be general protein degradation, together with the proteasome. The activity is increased by stress, such as during starvation and muscle wasting, and in tumour cells. Overexpression of TPP II leads Keywords: to accelerated cell growth, genetic instability and resistance to apoptosis, whereas inhibition or down- TPP II regulation of TPP II renders cells sensitive to apoptosis. Although it seems that humans can survive Proteasome Proteolysis without TPP II, it is not without consequences. Recently, patients with loss-of-function mutations in the fi Aminopeptidase TPP2 gene have been identi ed. They suffer from autoimmunity leading to leukopenia and other con- Evans disease sequences. Furthermore, a missense mutation in the TPP2 gene is associated with a sterile brain TRIANGLE disease inflammation condition mimicking multiple sclerosis. This review will summarise what is known today regarding the activity and structure of this very large enzyme complex, and its potential function in various cellular processes.
    [Show full text]